Biotin IgM antibodies in human blood: a previously unknown factor eliciting false results in biotinylation-based immunoassays.

Biotin is an essential vitamin that binds streptavidin or avidin with high affinity and specificity. As biotin is a small molecule that can be linked to proteins without affecting their biological activity, biotinylation is applied widely in biochemical assays. In our laboratory, IgM enzyme immuno a...

Full description

Bibliographic Details
Main Authors: Tingting Chen, Lea Hedman, Petri S Mattila, Laura Jartti, Tuomas Jartti, Olli Ruuskanen, Maria Söderlund-Venermo, Klaus Hedman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3411747?pdf=render
_version_ 1828407299933208576
author Tingting Chen
Lea Hedman
Petri S Mattila
Laura Jartti
Tuomas Jartti
Olli Ruuskanen
Maria Söderlund-Venermo
Klaus Hedman
author_facet Tingting Chen
Lea Hedman
Petri S Mattila
Laura Jartti
Tuomas Jartti
Olli Ruuskanen
Maria Söderlund-Venermo
Klaus Hedman
author_sort Tingting Chen
collection DOAJ
description Biotin is an essential vitamin that binds streptavidin or avidin with high affinity and specificity. As biotin is a small molecule that can be linked to proteins without affecting their biological activity, biotinylation is applied widely in biochemical assays. In our laboratory, IgM enzyme immuno assays (EIAs) of µ-capture format have been set up against many viruses, using as antigen biotinylated virus like particles (VLPs) detected by horseradish peroxidase-conjugated streptavidin. We recently encountered one serum sample reacting with the biotinylated VLP but not with the unbiotinylated one, suggesting in human sera the occurrence of biotin-reactive antibodies. In the present study, we search the general population (612 serum samples from adults and 678 from children) for IgM antibodies reactive with biotin and develop an indirect EIA for quantification of their levels and assessment of their seroprevalence. These IgM antibodies were present in 3% adults regardless of age, but were rarely found in children. The adverse effects of the biotin IgM on biotinylation-based immunoassays were assessed, including four inhouse and one commercial virus IgM EIAs, showing that biotin IgM do cause false positivities. The biotin can not bind IgM and streptavidin or avidin simultaneously, suggesting that these biotin-interactive compounds compete for the common binding site. In competitive inhibition assays, the affinities of biotin IgM antibodies ranged from 2.1 × 10(-3) to 1.7 × 10(-4 )mol/L. This is the first report on biotin antibodies found in humans, providing new information on biotinylation-based immunoassays as well as new insights into the biomedical effects of vitamins.
first_indexed 2024-12-10T11:23:37Z
format Article
id doaj.art-cf1be3ccbaf341d9bdadcb965da39160
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T11:23:37Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-cf1be3ccbaf341d9bdadcb965da391602022-12-22T01:50:51ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0178e4237610.1371/journal.pone.0042376Biotin IgM antibodies in human blood: a previously unknown factor eliciting false results in biotinylation-based immunoassays.Tingting ChenLea HedmanPetri S MattilaLaura JarttiTuomas JarttiOlli RuuskanenMaria Söderlund-VenermoKlaus HedmanBiotin is an essential vitamin that binds streptavidin or avidin with high affinity and specificity. As biotin is a small molecule that can be linked to proteins without affecting their biological activity, biotinylation is applied widely in biochemical assays. In our laboratory, IgM enzyme immuno assays (EIAs) of µ-capture format have been set up against many viruses, using as antigen biotinylated virus like particles (VLPs) detected by horseradish peroxidase-conjugated streptavidin. We recently encountered one serum sample reacting with the biotinylated VLP but not with the unbiotinylated one, suggesting in human sera the occurrence of biotin-reactive antibodies. In the present study, we search the general population (612 serum samples from adults and 678 from children) for IgM antibodies reactive with biotin and develop an indirect EIA for quantification of their levels and assessment of their seroprevalence. These IgM antibodies were present in 3% adults regardless of age, but were rarely found in children. The adverse effects of the biotin IgM on biotinylation-based immunoassays were assessed, including four inhouse and one commercial virus IgM EIAs, showing that biotin IgM do cause false positivities. The biotin can not bind IgM and streptavidin or avidin simultaneously, suggesting that these biotin-interactive compounds compete for the common binding site. In competitive inhibition assays, the affinities of biotin IgM antibodies ranged from 2.1 × 10(-3) to 1.7 × 10(-4 )mol/L. This is the first report on biotin antibodies found in humans, providing new information on biotinylation-based immunoassays as well as new insights into the biomedical effects of vitamins.http://europepmc.org/articles/PMC3411747?pdf=render
spellingShingle Tingting Chen
Lea Hedman
Petri S Mattila
Laura Jartti
Tuomas Jartti
Olli Ruuskanen
Maria Söderlund-Venermo
Klaus Hedman
Biotin IgM antibodies in human blood: a previously unknown factor eliciting false results in biotinylation-based immunoassays.
PLoS ONE
title Biotin IgM antibodies in human blood: a previously unknown factor eliciting false results in biotinylation-based immunoassays.
title_full Biotin IgM antibodies in human blood: a previously unknown factor eliciting false results in biotinylation-based immunoassays.
title_fullStr Biotin IgM antibodies in human blood: a previously unknown factor eliciting false results in biotinylation-based immunoassays.
title_full_unstemmed Biotin IgM antibodies in human blood: a previously unknown factor eliciting false results in biotinylation-based immunoassays.
title_short Biotin IgM antibodies in human blood: a previously unknown factor eliciting false results in biotinylation-based immunoassays.
title_sort biotin igm antibodies in human blood a previously unknown factor eliciting false results in biotinylation based immunoassays
url http://europepmc.org/articles/PMC3411747?pdf=render
work_keys_str_mv AT tingtingchen biotinigmantibodiesinhumanbloodapreviouslyunknownfactorelicitingfalseresultsinbiotinylationbasedimmunoassays
AT leahedman biotinigmantibodiesinhumanbloodapreviouslyunknownfactorelicitingfalseresultsinbiotinylationbasedimmunoassays
AT petrismattila biotinigmantibodiesinhumanbloodapreviouslyunknownfactorelicitingfalseresultsinbiotinylationbasedimmunoassays
AT laurajartti biotinigmantibodiesinhumanbloodapreviouslyunknownfactorelicitingfalseresultsinbiotinylationbasedimmunoassays
AT tuomasjartti biotinigmantibodiesinhumanbloodapreviouslyunknownfactorelicitingfalseresultsinbiotinylationbasedimmunoassays
AT olliruuskanen biotinigmantibodiesinhumanbloodapreviouslyunknownfactorelicitingfalseresultsinbiotinylationbasedimmunoassays
AT mariasoderlundvenermo biotinigmantibodiesinhumanbloodapreviouslyunknownfactorelicitingfalseresultsinbiotinylationbasedimmunoassays
AT klaushedman biotinigmantibodiesinhumanbloodapreviouslyunknownfactorelicitingfalseresultsinbiotinylationbasedimmunoassays